# Prime Medicine (PRME) — Earnings

PRME · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prme/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.32 |
| EPS estimate | −$0.25 |
| EPS surprise | −26.53% |
| Revenue surprise | −52.54% |
| Revenue | $1.2M |
| Revenue estimate | $2.6M |
| Reported | Nov 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1894562/000162828025050422/prme-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 7, 2025 | −$0.25 | −$0.32 | -26.53% | $2.6M | $1.2M |
| Q2 2025 | Aug 7, 2025 | −$0.35 | −$0.41 | -16.74% | $4.2M | $1.1M |
| Q1 2025 | May 8, 2025 | −$0.31 | −$0.40 | -27.59% | $4.5M | $1.5M |
| Q4 2024 | Feb 28, 2025 | −$0.38 | −$0.31 | 18.98% | $11.9M | $2.2M |
| Q3 2024 | Nov 12, 2024 | −$0.39 | −$0.44 | -14.20% | $7.1M | $204,500.00 |
| Q2 2024 | Aug 8, 2024 | −$0.39 | −$0.46 | -18.01% | $1.6M | — |
| Q1 2024 | May 10, 2024 | −$0.45 | −$0.44 | 3.28% | $1.9M | $591,000.00 |
| Q4 2023 | Mar 1, 2024 | −$0.56 | −$0.72 | -29.50% | $5.7M | — |
| Q3 2023 | Nov 3, 2023 | −$0.43 | −$0.55 | -26.67% | $1.7M | — |
| Q2 2023 | Aug 7, 2023 | −$0.42 | −$0.47 | -11.03% | — | — |
| Q1 2023 | May 11, 2023 | −$0.41 | −$0.44 | -6.18% | — | — |
| Q4 2022 | Mar 9, 2023 | −$1.59 | −$0.56 | 64.78% | — | — |

## Frequently Asked Questions

### When did Prime Medicine (PRME) last report earnings?

Prime Medicine last reported on Nov 7, 2025, covering fiscal Q3 2025.

### Did PRME beat earnings estimates?

No. Prime Medicine reported EPS of −$0.32 for Q3 2025 against a −$0.25 estimate — a 26.53% miss.

### How much revenue did PRME report last quarter?

Prime Medicine reported $1.2M in revenue for Q3 2025, against a consensus estimate of $2.6M.

## Similar Stocks

- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock
- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).